TUNIU CORP-SPON ADR (TOUR)

US89977P1066 - ADR

0.9138  -0.01 (-1.17%)

After market: 0.9196 +0.01 (+0.63%)

Fundamental Rating

4

TOUR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. TOUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TOUR has a decent growth rate and is not valued too expensively.



2

1. Profitability

1.1 Basic Checks

In the past year TOUR was profitable.
TOUR had negative earnings in each of the past 5 years.
TOUR had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

TOUR has a Return On Assets of 1.36%. This is in the lower half of the industry: TOUR underperforms 60.90% of its industry peers.
TOUR's Return On Equity of 2.47% is in line compared to the rest of the industry. TOUR outperforms 51.13% of its industry peers.
The Return On Invested Capital of TOUR (0.08%) is worse than 79.70% of its industry peers.
Industry RankSector Rank
ROA 1.36%
ROE 2.47%
ROIC 0.08%
ROA(3y)-18.84%
ROA(5y)-13.99%
ROE(3y)-40.5%
ROE(5y)-30.58%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TOUR's Profit Margin of 7.78% is fine compared to the rest of the industry. TOUR outperforms 67.67% of its industry peers.
TOUR's Operating Margin of 0.33% is on the low side compared to the rest of the industry. TOUR is outperformed by 78.20% of its industry peers.
TOUR has a Gross Margin of 62.73%. This is in the better half of the industry: TOUR outperforms 70.68% of its industry peers.
In the last couple of years the Gross Margin of TOUR has declined.
Industry RankSector Rank
OM 0.33%
PM (TTM) 7.78%
GM 62.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.06%
GM growth 5Y-1.7%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TOUR is destroying value.
TOUR has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for TOUR remains at a similar level compared to 5 years ago.
TOUR has a better debt/assets ratio than last year.

2.2 Solvency

TOUR has an Altman-Z score of -4.35. This is a bad value and indicates that TOUR is not financially healthy and even has some risk of bankruptcy.
TOUR has a worse Altman-Z score (-4.35) than 96.99% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that TOUR is not too dependend on debt financing.
TOUR has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. TOUR outperforms 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -4.35
ROIC/WACC0.01
WACC7.83%

2.3 Liquidity

TOUR has a Current Ratio of 1.55. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
TOUR has a better Current ratio (1.55) than 75.19% of its industry peers.
TOUR has a Quick Ratio of 1.55. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.55, TOUR is in the better half of the industry, outperforming 75.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55

6

3. Growth

3.1 Past

TOUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 113.33%, which is quite impressive.
Looking at the last year, TOUR shows a very strong growth in Revenue. The Revenue has grown by 60.44%.
The Revenue for TOUR have been decreasing by -39.08% on average. This is quite bad
EPS 1Y (TTM)113.33%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q335.2%
Revenue 1Y (TTM)60.44%
Revenue growth 3Y-56.79%
Revenue growth 5Y-39.08%
Revenue growth Q2Q128.75%

3.2 Future

TOUR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.56% yearly.
The Revenue is expected to grow by 151.66% on average over the next years. This is a very strong growth
EPS Next Y224.74%
EPS Next 2Y110.96%
EPS Next 3Y75.77%
EPS Next 5Y58.56%
Revenue Next Year1631.12%
Revenue Next 2Y396.86%
Revenue Next 3Y224.02%
Revenue Next 5Y151.66%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

TOUR is valuated rather expensively with a Price/Earnings ratio of 22.84.
Based on the Price/Earnings ratio, TOUR is valued a bit cheaper than the industry average as 60.15% of the companies are valued more expensively.
TOUR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.02, which is the current average of the S&P500 Index.
TOUR is valuated reasonably with a Price/Forward Earnings ratio of 11.74.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TOUR indicates a rather cheap valuation: TOUR is cheaper than 85.71% of the companies listed in the same industry.
TOUR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.58, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.85
Fwd PE 11.74

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -43.13

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TOUR's earnings are expected to grow with 75.77% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y110.96%
EPS Next 3Y75.77%

0

5. Dividend

5.1 Amount

No dividends for TOUR!.
Industry RankSector Rank
Dividend Yield N/A

TUNIU CORP-SPON ADR

NASDAQ:TOUR (5/6/2024, 7:00:02 PM)

After market: 0.9196 +0.01 (+0.63%)

0.9138

-0.01 (-1.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap107.88M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 22.85
Fwd PE 11.74
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.47%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.33%
PM (TTM) 7.78%
GM 62.73%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)113.33%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y224.74%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)60.44%
Revenue growth 3Y-56.79%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y